ENN-01

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameENN-01
Drug Alias NameENN-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsPlaque psoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEnnar Pharmaceuticals Af
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnnar Pharmaceuticals Af
Active IndicationsN/A
Inactive IndicationsPlaque psoriasis

Other Information

ATC CodeN/A
Related LinksN/A